BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33087507)

  • 21. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
    Kamer S; Ren Q; Dicker AP
    Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
    Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
    Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism.
    Mattson DM; Ahmad IM; Dayal D; Parsons AD; Aykin-Burns N; Li L; Orcutt KP; Spitz DR; Dornfeld KJ; Simons AL
    Free Radic Biol Med; 2009 Jan; 46(2):232-7. PubMed ID: 18983911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
    Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
    Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
    Wangpaichitr M; Wu C; Li YY; Nguyen DJM; Kandemir H; Shah S; Chen S; Feun LG; Prince JS; Kuo MT; Savaraj N
    Oncotarget; 2017 Jul; 8(30):49275-49292. PubMed ID: 28525376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vemurafenib resistance reprograms melanoma cells towards glutamine dependence.
    Hernandez-Davies JE; Tran TQ; Reid MA; Rosales KR; Lowman XH; Pan M; Moriceau G; Yang Y; Wu J; Lo RS; Kong M
    J Transl Med; 2015 Jul; 13():210. PubMed ID: 26139106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
    Scarbrough PM; Mapuskar KA; Mattson DM; Gius D; Watson WH; Spitz DR
    Free Radic Biol Med; 2012 Jan; 52(2):436-43. PubMed ID: 22100505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells.
    Chang HW; Lee M; Lee YS; Kim SH; Lee JC; Park JJ; Nam HY; Kim MR; Han MW; Kim SW; Kim SY
    Cell Signal; 2021 Jan; 77():109820. PubMed ID: 33137455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer.
    Coleman MC; Asbury CR; Daniels D; Du J; Aykin-Burns N; Smith BJ; Li L; Spitz DR; Cullen JJ
    Free Radic Biol Med; 2008 Feb; 44(3):322-31. PubMed ID: 18215740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A facile and sensitive method of quantifying glutaminase binding to its inhibitor CB-839 in tissues.
    Chen Y; Zhao Y; Bajor DL; Wang Z; Selfridge JE
    J Genet Genomics; 2020 Jul; 47(7):389-395. PubMed ID: 33004309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
    Gregory MA; Nemkov T; Reisz JA; Zaberezhnyy V; Hansen KC; D'Alessandro A; DeGregori J
    Exp Hematol; 2018 Feb; 58():52-58. PubMed ID: 28947392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
    Masamha CP; LaFontaine P
    J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel.
    Kloepping KC; Kraus AS; Hedlund DK; Gnade CM; Wagner BA; McCormick ML; Fath MA; Seol D; Lim TH; Buettner GR; Goswami PC; Pigge FC; Spitz DR; Schultz MK
    PLoS One; 2020; 15(12):e0244540. PubMed ID: 33378390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
    Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B
    Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer.
    Jin H; Wang S; Zaal EA; Wang C; Wu H; Bosma A; Jochems F; Isima N; Jin G; Lieftink C; Beijersbergen R; Berkers CR; Qin W; Bernards R
    Elife; 2020 Oct; 9():. PubMed ID: 33016874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutaminases regulate glutathione and oxidative stress in cancer.
    Matés JM; Campos-Sandoval JA; de Los Santos-Jiménez J; Márquez J
    Arch Toxicol; 2020 Aug; 94(8):2603-2623. PubMed ID: 32681190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.
    Li L; Nie L; Jordan A; Cai Q; Liu Y; Li Y; Che Y; Vargas J; Chen Z; Leeming A; Wang W; Yao Y; Wang M; Jiang VC
    Haematologica; 2023 Jun; 108(6):1616-1627. PubMed ID: 36420799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
    Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
    Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
    Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
    Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells.
    Li JL; Wang JP; Chang H; Deng SM; Du JH; Wang XX; Hu HJ; Li DY; Xu XB; Guo WQ; Song YH; Guo Z; Sun MX; Wu YW; Liu SB
    Cancer Med; 2019 Dec; 8(18):7774-7780. PubMed ID: 31670906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.